MMP3 and rheumatoid arthritis: MMP-3 levels and US7 scores decreased significantly in the second week after treatment with certolizumab pegol (Cimzia; UCB, Brussels, Belgium), which confirmed that serum MMP-3 levels and US7 scores could reflect the disease activity and treatment response in moderate and severe RA (41).